Myrtucommulone (MC) and semimyrtucommulone (S-MC) are unique oligomeric, nonprenylated acylphloroglucinols contained in the leaves of myrtle (Myrtus communis). Although extracts of myrtle have been traditionally used in folk medicine for the treatment of various disorders, studies addressing select cellular or molecular pharmacological properties of these extracts or specific ingredients thereof are rare. Here, we show for the first time that MC and S-MC potently suppress the biosynthesis of eicosanoids by direct inhibiting cyclooxygenase-1 and 5-lipoxygenase in vitro and in vivo at IC 50 values in the range of 1.8 to 29 M. Moreover, we show that MC and S-MC prevent the mobilization of Ca 2ϩ in polymorphonuclear leukocytes, mediated by G protein signaling pathways at IC 50 values of 0.55 and 4.5 M, respectively, and suppress the formation of reactive oxygen species and the release of elastase at comparable concentrations. The isobutyrophenone core of MC as well as S-MC was much less potent or even not active at all. In addition, MC or S-MC only partially inhibited peroxide formation or failed to block Ca 2ϩ mobilization and elastase release when polymorphonuclear leukocytes were challenged with ionomycin that circumvents G protein signaling for cell activation. We conclude that, in view of their ability to suppress typical proinflammatory cellular responses, the unique acylphloroglucinols MC and S-MC from myrtle may possess an anti-inflammatory potential, suggesting their therapeutic use for the treatment of diseases related to inflammation and allergy.Myrtle (Myrtus communis, Myrtaceae) is a Mediterranean shrub used as a culinary spice and as a folk medicine, for example, in the treatment of diabetes mellitus and as an antiseptic agent. In fact, myrtle extracts have been reported to possess antihyperglycemic (Elfellah et al., 1984;Sepici et al., 2004;Onal et al., 2005), antibacterial (Al-Saimary et al., 2002;Bonjar, 2004), and analgesic (Levesque and Lafont, 2000) properties. Recent reports have described antioxidant activities of different extracts of myrtle and certain ingredients thereof (Rosa et al., 2003;Hayder et al., 2004;Romani et al., 2004), implying potential as medicine for the treatment of diseases related to oxidative stress, including inflammatory disorders. Myrtle contains a great variety of compounds like bitter substances, ethereal oil, and tannic substances (elSissi and el-Ansary, 1967). In addition to these rather ubiquitous ingredients that are present in many plants, myrtle contains unique oligomeric, nonprenylated acylphloroglucinols such as myrtucommulone (MC) and semimyrtucommulone (S-MC) (Appendino et al., 2002), which are considered to be responsible for the antioxidative (Rosa et al., 2003)